Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2197-2025

IontoPatch 80, On-the-Go Patch Therapy Recall

IontoPatch 80, On-the-Go Patch Therapy, Model/Catalog Number: D-0077-080; The IontoPatch is an Iontophoresis transdermal patch.

FDA recall Class II

Ongoing

FDA lists this Class II recall for IontoPatch 80, On-the-Go Patch Therapy. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2197-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
May 22, 2025
FDA report date
Aug 6, 2025
Quantity in commerce
63936 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

IontoPatch 80, On-the-Go Patch Therapy, Model/Catalog Number: D-0077-080; The IontoPatch is an Iontophoresis transdermal patch.

Affected model & UDI checker

Search the exact identifiers published for Z-2197-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
D-0077-080IontoPatch 80, On-the-Go Patch TherapyCheck source noticeNot specified
FDA code information

Lot Code: UDI-DI: (01) 10815611020012 UDI-PI: (10) 4303 Lot numbers: 4303-1, 4303-2, 4303-3

View the original FDA recall notice

Why was this product recalled?

The nonwoven pads in the device do not absorb the saline solution or any other liquid intended to be used with the device.

What actions did LTS Therapy Systems, LLC take?

LTS issued an URGENT: Medical Device Removal, Initial Notification to its consignees on 05/22/2025 via telephone and email. The notice explained the issue, the risk to health, and requested the following: Actions to be taken by the distributor: 1. Please stop all distribution of IontoPatch STAT Lot # s 4283-1, 4283-2, 4283-3, 4283-4 and IontoPatch 80 Lot # s 4303-1, 4303-2, 4303-3. 2. Contact your clients to which these product lot # s have been distributed and instruct them to cease all sales, distribution and/or usage. Further Actions: 1. This initial notification is to stop further distribution of products only. In the coming days, LTS will request the following: a. The quantity of each product and lot # s listed above at your facility b. The quantity of each product and lot # s listed above that you have distributed c. The companies name and address where products have been sold, along with the quantities of each product and lot number sold d. The remaining quantity of each product and lot number at all company locations where product was sold 2. LTS will provide information for the return and reimbursement of products. Please contact Steve Leno for any questions or additional information: Email: [email protected]; Ph: 651-552-5622

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology